Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
0.4140
+0.0230 (5.88%)
Jul 23, 2025, 1:00 PM - Market open

Equillium Revenue

Equillium had revenue of $30.41M in the twelve months ending March 31, 2025, down -19.76% year-over-year. In the year 2024, Equillium had annual revenue of $41.10M with 13.89% growth.

Revenue (ttm)
$30.41M
Revenue Growth
-19.76%
P/S Ratio
0.46
Revenue / Employee
$868,743
Employees
35
Market Cap
14.79M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202441.10M5.01M13.89%
Dec 31, 202336.08M20.33M128.97%
Dec 31, 202215.76M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group410.06B
Johnson & Johnson90.63B
Merck & Co.63.92B
AbbVie57.37B
Novartis AG55.19B
AstraZeneca54.98B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings